Company intelligence / Profile preview

PharmaVigilant

Westborough, Massachusetts, USA

Ownership: Private
Development stage: Other

Overview

PharmaVigilant was a clinical trial technology company that provided a comprehensive suite of SaaS-based solutions for the life sciences industry. Its core offerings included electronic data capture (EDC), electronic trial master files (eTMF), and clinical data management systems, all designed to streamline the clinical research process. The company's 'I-Vault' and 'I-Trial' platforms focused on improving data quality, ensuring regulatory compliance, and reducing the time and cost of clinical trials. PharmaVigilant served a diverse range of pharmaceutical, biotechnology, and medical device sponsors. In June 2012, the company was acquired by Sparta Systems to bolster its quality management and compliance portfolio.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on PharmaVigilant.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PharmaVigilant.

Explore the full profile